Ajanta Pharma has reported results for third quarter ended December 31, 2022.
The company has reported fall of 36.34% in its net profit at Rs 123.96 crore for Q3FY23 as compared to Rs 194.71 crore for the corresponding quarter previous year. However, total income of the company increased by 8.24% to Rs 905.40 crore for the quarter under review as compared to Rs 836.48 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported fall of 29.86% in its net profit at Rs 134.51 crore for Q3FY23 as compared to Rs 191.78 crore for the same quarter in the previous year. However, total income of the company increased by 16.79% to Rs 1,006.70 crore for the quarter under review as compared to Rs 861.94 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |